Expression Table for this CRE
| CNhs14080 | locus coeruleus, newborn, donor10223 | 2.3 |
| CNhs12862 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 0.9 |
| CNhs14525 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 0.8 |
| SRX9760357 | skeletal muscle_1_h_after_exercise (Individual 2) | 0.7 |
| CNhs13832 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1 | 0.7 |
| SRX4504766 | human NET-CAGE GM12878, biol_rep1 | 0.7 |
| SRX9760351 | skeletal muscle_3_h_after_exercise (Individual 7) | 0.6 |
| SRX9760358 | skeletal muscle_3_h_after_exercise (Individual 2) | 0.5 |
| SRX9760344 | skeletal muscle_2_min_after_exercise (Individual 6) | 0.5 |
| SRX9760356 | skeletal muscle_2_min_after_exercise (Individual 2) | 0.4 |
| SRX6586366 | CNhi10369_MCF-7_siRNA-negative control-48h_rep2 | 0.4 |
| CNhs11776 | skeletal muscle, fetal, donor1 | 0.3 |
| CNhs13364 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 0.3 |
| SRX9760369 | skeletal muscle_prior_exercise (Individual 8) | 0.3 |
| SRX6586278 | CNhi10372_THP-1_Simvastatin-30 uM-6h_rep2 | 0.3 |
| CNhs13372 | Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41) | 0.3 |
| CNhs14062 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 0.3 |
| CNhs12924 | Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1) | 0.2 |
| SRX4504725 | human CAGE MCF-7, response to HRG, 60 min, biol_rep3 | 0.2 |
| CNhs14068 | H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2 | 0.2 |
| SRX6586374 | CNhi10370_MCF-7_siRNA (HSS179267) treatment-48h_rep2 | 0.2 |
| SRX6586267 | CNhi10334.AJ_THP-1_siRNA (HSS179267) treatment-48h_rep3 | 0.2 |
| CNhs14067 | H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1 | 0.2 |
| CNhs14537 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 0.2 |
| CNhs13429 | mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2 | 0.2 |
| CNhs14056 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3 | 0.1 |
| CNhs13110 | Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 0.1 |
| SRX9760334 | skeletal muscle_prior_exercise (Individual 1) | 0.1 |
| SRX6586377 | CNhi10325_THP-1_Non-treatment (DMSO)-6h_rep2 | 0.1 |
| CNhs12334 | chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1 | 0.1 |
| SRX6586370 | CNhi10369_MCF-7_siRNA-negative control-48h_rep6 | 0.1 |
| SRX6586289 | CNhi10324_HepG2_Atrovastatin-30 uM-48h_rep2 | 0.1 |
| SRX6586292 | CNhi10324_HepG2_Fluvastatin-30 uM-48h_rep2 | 0.1 |
| SRX6586265 | CNhi10334.AD_THP-1_siRNA-negative control-48h_rep6 | 0.1 |
| SRX6586270 | CNhi10371_THP-1_Non-treatment (DMSO)-6h_rep3 | 0.1 |
| SRX6586293 | CNhi10324_HepG2_Simvastatin-30 uM-48h_rep1 | 0.1 |
| SRX6586291 | CNhi10324_HepG2_Fluvastatin-30 uM-48h_rep1 | 0.1 |
| SRX6586287 | CNhi10373_THP-1_Rosuvastatin-30 uM-6h_rep3 | 0.1 |
| SRX6586381 | CNhi10326_THP-1_Atrovastatin-30 uM-6h_rep2 | 0.1 |
| SRX6586271 | CNhi10371_THP-1_Non-treatment (DMSO)-6h_rep4 | 0.1 |
| SRX6586285 | CNhi10373_THP-1_Rosuvastatin-30 uM-6h_rep1 | 0.1 |
| SRX6586288 | CNhi10324_HepG2_Atrovastatin-30 uM-48h_rep1 | 0.1 |
| SRX6586283 | CNhi10373_THP-1_Non-treatment (DMSO)-48h_rep1 | 0.1 |
| SRX6586284 | CNhi10373_THP-1_Non-treatment (DMSO)-48h_rep2 | 0.1 |
| SRX6586280 | CNhi10373_THP-1_Fluvastatin-30 uM-6h_rep1 | 0.1 |
| SRX6586290 | CNhi10324_HepG2_Atrovastatin-30 uM-48h_rep3 | 0.1 |
| ERX10345068 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345069 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345070 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |
| ERX10345071 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |